By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences disclosed in a filing today with the US Securities and Exchange Commission that it has received a notice from the Nasdaq Stock Market that it did not achieve compliance with the $1 bid price requirement under listing rules by Feb. 13, 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.